{
    "root": "5a7fd241-20e6-403d-a080-ed2168b5695f",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "Human Prescription Drug Label",
    "name": {
        "text": "Estradiol Gel"
    },
    "value": "20250128",
    "ingredients": [
        {
            "name": "ESTRADIOL",
            "code": "4TI98Z838E"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3"
        },
        {
            "name": "TROLAMINE",
            "code": "9O3K93S3TK"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        },
        {
            "name": "ALCOHOL",
            "code": "3K9958V90M"
        },
        {
            "name": "CARBOMER HOMOPOLYMER TYPE B",
            "code": "HHT01ZNK31"
        }
    ],
    "indications": "estradiol gel 0.1 % estrogen indicated treatment moderate severe vasomotor symptoms due menopause ( 1.1 ) .",
    "contraindications": "generally , estrogen prescribed postmenopausal woman uterus , consider addition progestogen reduce risk endometrial cancer.generally , woman without uterus , need progestogen addition estrogen therapy . cases , however , hysterectomized women history endometriosis may need progestogen [ ( 5.2 , 5.14 ) ] . estrogen-alone , combination progestogen , lowest effective dose shortest duration consistent treatment goals risks individual woman . reevaluate postmenopausal women periodically clinically appropriate determine whether treatment still necessary .",
    "warningsAndPrecautions": null,
    "adverseReactions": "estradiol gel 0.1 % contraindicated women following conditions : \u2022 undiagnosed abnormal genital bleeding [ warning ( 5.2 ) ] \u2022 breast cancer history breast cancer [ warning ( 5.2 ) ] \u2022 estrogen-dependent neoplasia [ warning ( 5.2 ) ] \u2022 active dvt , pe , history conditions [ warning ( 5.1 ) ] \u2022 active arterial thromboembolic disease ( e.g . , stroke myocardial infarction ) , history conditions [ warning ( 5.1 ) ] \u2022 known anaphylactic reaction , angioedema , hypersensitivity estradiol gel 0.1 % \u2022 hepatic impairment disease \u2022 protein c , protein , antithrombin deficiency , known thrombophilic disorders",
    "indications_original": "Estradiol gel 0.1% is an estrogen indicated for the treatment of moderate to severe vasomotor symptoms due to menopause (1.1).",
    "contraindications_original": "Generally, when estrogen is prescribed for a postmenopausal woman with a uterus, consider addition of a progestogen to reduce the risk of endometrial cancer.Generally, a woman without a uterus, does not need a progestogen in addition to her estrogen therapy. In some cases, however, hysterectomized women who have a history of endometriosis may need a progestogen [see Warnings and Precautions (5.2, 5.14)].\n                      Use estrogen-alone, or in combination with a progestogen, at the lowest effective dose and for the shortest duration consistent with treatment goals and risks for the individual woman. Reevaluate postmenopausal women periodically as clinically appropriate to determine whether treatment is still necessary.",
    "adverseReactions_original": "Estradiol gel 0.1% is contraindicated in women with any of the following conditions: \u00a0\u00a0\u00a0\u00a0\u2022 Undiagnosed abnormal genital bleeding [see Warning and Precautions (5.2)]\n                      \u00a0\u00a0\u00a0\u00a0\u2022 Breast cancer or history of breast cancer [see Warning and Precautions (5.2)]\n                      \u00a0\u00a0\u00a0\u00a0\u2022 Estrogen-dependent neoplasia [see Warning and Precautions (5.2)]\n                      \u00a0\u00a0\u00a0\u00a0\u2022 Active DVT, PE, or history of these conditions [see Warning and Precautions (5.1)]\n                      \u00a0\u00a0\u00a0\u00a0\u2022 Active arterial thromboembolic disease (e.g., stroke and MI), or a history of these conditions [see Warning and Precautions (5.1)]\n                      \u00a0\u00a0\u00a0\u00a0\u2022 Known anaphylactic reaction, angioedema, or hypersensitivity to estradiol gel 0.1% \u00a0\u00a0\u00a0\u00a0\u2022 Hepatic impairment or disease \u00a0\u00a0\u00a0\u00a0\u2022 Protein C, protein S, or antithrombin deficiency, or other known thrombophilic disorders"
}